Correlation Between Quoin Pharmaceuticals and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Moleculin Biotech, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Moleculin Biotech.
Diversification Opportunities for Quoin Pharmaceuticals and Moleculin Biotech
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Quoin and Moleculin is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and Moleculin Biotech
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Moleculin Biotech. In addition to that, Quoin Pharmaceuticals is 1.29 times more volatile than Moleculin Biotech. It trades about -0.06 of its total potential returns per unit of risk. Moleculin Biotech is currently generating about -0.04 per unit of volatility. If you would invest 2,025 in Moleculin Biotech on September 4, 2024 and sell it today you would lose (1,756) from holding Moleculin Biotech or give up 86.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. Moleculin Biotech
Performance |
| Timeline |
| Quoin Pharmaceuticals |
| Moleculin Biotech |
Quoin Pharmaceuticals and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quoin Pharmaceuticals and Moleculin Biotech
The main advantage of trading using opposite Quoin Pharmaceuticals and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| Quoin Pharmaceuticals vs. Candel Therapeutics | Quoin Pharmaceuticals vs. Cingulate Warrants | Quoin Pharmaceuticals vs. Unicycive Therapeutics | Quoin Pharmaceuticals vs. Cardio Diagnostics Holdings |
| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |